Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention

American Heart Journal

Volumn 150, Issue 5, 2005, Pages 1000-1006

  Straumann, Edwin ^a   Kurz, David J ^a   Muntwyler, Jörg ^b   Stettler, Irene ^c   Furrer, Marcel ^a   Naegeli, Barbara ^a   Frielingsdorf, Jürgen ^a   Schuiki, Ernst ^a   Mury, Raymond ^a   Bertel, Osmund ^a   Spinas, Giatgen A ^b  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Triemli Hospital Zurich ^*

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FEMALE; FLOW RATE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT CODING; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 27744590937     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.01.033     Document Type: Article

References (29)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
2. P. Hildebrandt Diabetic patients and acute coronary syndromes Eur Heart J 22 2001 887 888
3. H. Lowel, W. Koenig, and S. Engel The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study Diabetologia 43 2000 218 226
4. D.K. McGuire, H. Emanuelsson, and C.B. Granger Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators Eur Heart J 21 2000 1750 1758
5. K. Malmberg, L. Ryden, and S. Efendic Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year J Am Coll Cardiol 26 1995 57 65
6. K. Malmberg, A. Norhammar, and H. Wedel Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study Circulation 99 1999 2626 2632
7. A.M. Norhammar, L. Ryden, and K. Malmberg Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients Diabetes Care 22 1999 1827 1831
8. K. Foo, J. Cooper, and A. Deaner A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes Heart 89 2003 512 516
9. S.E. Capes, D. Hunt, and K. Malmberg Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 2000 773 778
10. R.C. Becker, M. Burns, and J.M. Gore Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants Am Heart J 135 1998 786 796
11. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 36 2003 13 20
12. H.R. Andersen, T.T. Nielsen, and K. Rasmussen A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
13. P. Widimsky, L. Groch, and M. Zelizko Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study Eur Heart J 21 2000 823 831
14. Q. Qiao, K. Pyorala, and M. Pyorala Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose Eur Heart J 23 2002 1267 1275
15. M.D. Siperstein The glucose tolerance test: a pitfall in the diagnosis of diabetes mellitus Adv Intern Med 20 1975 297 323
16. R.M. Califf, and J.R. Bengtson Cardiogenic shock N Engl J Med 330 1994 1724 1730
17. A. Norhammar, A. Tenerz, and G. Nilsson Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Lancet 359 2002 2140 2144
18. S.P. Allison, P.J. Tomlin, and M.J. Chamberlain Some effects of anaesthesia and surgery on carbohydrate and fat metabolism Br J Anaesth 41 1969 588 592
19. R.S.J. Clarke, H. Johnston, and B. Sheridan The influence of anaesthesis and surgery on plasma cortisol, insulin and free fatty acids Br J Anaesth 42 1970 295 299
20. M.F. Oliver, and L.H. Opie Effects of glucose and fatty acids on myocardial ischaemia and arrythmias Lancet 343 1994 155 158
21. O.D. Mjos Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs J Clin Invest 50 1971 1386 1389
22. I. Stranders, M. Diamant, and R.E. van Gelder Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus Arch Intern Med 164 2004 982 988
23. N. Wahab, E.A. Cowden, and N.J. Pearce Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40 2002 1748 1754
24. I. Gustafsson, P. Hildebrandt, and M. Seibaek Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The ACE Study Group Eur Heart J 21 2000 1937 1943
25. O. Schnell, O. Schafer, and S. Kleybrink Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry Diabetes Care 27 2004 455 460
26. D.A. Morrow, E.M. Antman, and A. Charlesworth TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
27. M.S. Sabatine, and E.M. Antman The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction J Am Coll Cardiol 41 4 Suppl S 2003 89S 95S
28. U. Stenestrand, and L. Wallentin Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study Lancet 359 2002 1805 1811
29. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887